The role of the modern core clinical laboratory
The core laboratory supports a broad range of diagnostic services using clinical chemistry analysers and immunoassay platforms. These systems are routinely used to measure electrolytes, liver function markers, renal function markers, lipid profiles, therapeutic drug levels, cardiac markers, tumour markers and endocrine biomarkers. The breadth of this testing means laboratories must maintain consistent analytical performance across large analyte menus while managing multiple instruments, reagent systems and quality requirements.
As testing volumes increase and healthcare organisations consolidate laboratory services, standardising quality management across analyser platforms becomes a growing priority. Laboratory managers are often tasked with reducing variation between systems, simplifying quality control processes and maintaining readiness for accreditation inspections without compromising analytical performance.
The QC challenge across chemistry and immunoassay
Quality control within the core laboratory extends beyond identifying assay failures. Laboratories must monitor performance across multiple analysers, evaluate reagent lot changes, investigate shifts in control recovery and maintain documented evidence of ongoing assay reliability.
Chemistry and immunoassay departments frequently operate instruments from different manufacturers, each with its own reagents, calibrators and recommended controls. As a result, QC programmes can become fragmented, increasing inventory requirements and creating additional review and documentation workloads. Effective QC strategies help laboratories detect calibration drift, reagent instability and analytical shifts before patient results are affected.
Third-party controls versus in-kit controls
Manufacturer-supplied controls play an important role in routine testing, but many laboratories also include independent third-party controls within their quality programme. Unlike in-kit controls, third-party controls are produced independently of the analyser, reagents and calibrators used during testing.
Because they are not optimised for a specific analytical system, independent controls can provide a more objective assessment of performance. They may help laboratories identify analytical shifts associated with reagent changes, calibration issues or instrument-related factors that could otherwise remain undetected. For organisations seeking to standardise quality practices across several analyser platforms, third-party controls can also support more consistent QC workflows.
Reagent lot changes and QC reassignment
Reagent lot changes remain one of the most common causes of QC investigations in clinical chemistry and immunoassay laboratories. Even when a new lot meets manufacturer specifications, laboratories may observe changes in control recovery, bias or established means.
Before introducing a new lot into routine testing, laboratories should perform documented verification studies and review QC performance against predefined acceptance criteria. Independent controls and peer comparison data can help identify clinically significant shifts, reducing the risk of unintended analytical variation and unnecessary corrective actions.
Consolidating controls across analyser platforms
Consideration | Manufacturer controls | Independent third-party controls |
Platform coverage | Usually manufacturer-specific | Compatible with multiple platforms |
QC standardisation | Limited across sites | Supports standardisation |
Inventory management | Multiple products required | Reduced inventory complexity |
Peer comparison | Method specific | Broad peer group analytics |
Training requirements | Platform dependent | Consistent QC workflows |
Procurement | Multiple suppliers | Simplified purchasing |
For multi-site healthcare systems and consolidated laboratory networks, reducing the number of QC products used across departments can simplify training, inventory management and quality review processes while supporting a more consistent approach to quality management.
Quality control across clinical chemistry and immunoassay platforms
Clinical chemistry analysers support testing across electrolyte panels, comprehensive metabolic panels, liver function testing, renal function assessments and lipid profiling, while immunoassay platforms are widely used for endocrine testing, cardiac biomarker analysis, infectious disease screening and tumour marker measurement. Across both disciplines, laboratories must demonstrate stable analytical performance at clinically relevant decision points while maintaining acceptable precision, bias and recovery throughout the reportable range.
Independent quality controls help laboratories monitor assay consistency, evaluate reagent performance and identify shifts that may influence patient results. They also provide ongoing evidence that established analytical performance claims remain valid following maintenance activities, calibration events and reagent lot changes.
Calibration verification and linearity studies
Calibration verification is an important component of laboratory quality management and may be required to demonstrate that reported results remain accurate throughout the analytical measurement range. These studies help laboratories confirm that analyser performance remains suitable following calibration, maintenance or method changes.
Calibration verification materials support reportable range studies, analytical measurement assessments and documentation required for inspection activities. Regular verification activities can also provide confidence that performance remains aligned with established analytical expectations over time.
Proficiency testing and external quality assessment
While internal quality control demonstrates day-to-day assay performance, proficiency testing provides external confirmation of laboratory competency. By comparing results against peer laboratories, organisations can identify systematic bias, evaluate performance trends and demonstrate ongoing compliance with accreditation requirements.
Participation in proficiency testing and external quality assessment programmes complements routine QC by providing independent evidence of laboratory performance. Together, these activities support a comprehensive quality management strategy and continuous quality improvement.
Preparing for CAP and CLIA inspection
Inspection readiness depends on more than acceptable QC performance. Laboratories must maintain complete documentation demonstrating that quality activities are routinely performed, reviewed and acted upon when necessary.
Inspectors commonly review quality control records, calibration verification studies, reportable range documentation, proficiency testing performance, corrective action investigations, reagent lot verification records and evidence of ongoing monitoring. Laboratories with well-documented quality systems are typically better positioned to demonstrate compliance, support accreditation activities and respond efficiently during inspections.
:quality(75))